{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "15065867", "DateCompleted": {"Year": "2004", "Month": "08", "Day": "06"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "09"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0006-2960", "JournalIssue": {"Volume": "43", "Issue": "14", "PubDate": {"Year": "2004", "Month": "Apr", "Day": "13"}}, "Title": "Biochemistry", "ISOAbbreviation": "Biochemistry"}, "ArticleTitle": "Differences in biochemical properties and in biological function between human SP-A1 and SP-A2 variants, and the impact of ozone-induced oxidation.", "Pagination": {"StartPage": "4227", "EndPage": "4239", "MedlinePgn": "4227-39"}, "Abstract": {"AbstractText": ["The human surfactant protein A (SP-A) locus consists of two functional genes, SP-A1 and SP-A2, with several alleles characterized for each gene. Functional variations between SP-A1 and SP-A2 variants either before or after ozone exposure have been observed. To understand the basis of these differences, we studied SP-A1 and SP-A2 variants by comparing coding sequences, oligomerization patterns under various conditions, composition of oligomers with regard to amino terminal sequence isoforms, biological activity (regulation of phosphatidylcholine (PC) secretion by alveolar type II cells), and the impact of ozone-induced oxidation. We found that (i) the SP-A1 (6A(4)) allele is the most divergent from all SP-A2 alleles, particularly from the SP-A2 (1A(1)). (ii) Differences exist in oligomerization among SP-A1, SP-A2, and coexpressed SP-A1/SP-A2, with higher order multimers (i.e., consisting of more subunits) observed for SP-A1 than for SP-A2 variants. Differences among SP-A1 or SP-A2 gene products are minimal. (iii) Amino acid variants in the amino terminal sequences are observed after signal peptide removal, including variants with an extra cysteine. (iv) Oxidation is observed after ozone exposure, involving several SP-A residues that include cysteine, methionine, and tryptophan. (v) The SP-A2 variant (1A(0)) and the coexpressed protein 1A(0)/6A(2) inhibit ATP-stimulated PC secretion from alveolar type II cells to a greater extent than SP-A1 (6A(2)), a biologic activity that was susceptible to ozone treatment."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Cellular and Molecular Physiology, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033, USA."}], "Identifier": [], "LastName": "Wang", "ForeName": "Guirong", "Initials": "G"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Bates-Kenney", "ForeName": "Sandra R", "Initials": "SR"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Tao", "ForeName": "Jian-Qin", "Initials": "JQ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Phelps", "ForeName": "David S", "Initials": "DS"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Floros", "ForeName": "Joanna", "Initials": "J"}], "GrantList": [{"GrantID": "19737", "Agency": "PHS HHS", "Country": "United States"}, {"GrantID": "1R01 ES09882-01", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Comparative Study", "Journal Article", "Research Support, U.S. Gov't, P.H.S."]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Biochemistry", "NlmUniqueID": "0370623", "ISSNLinking": "0006-2960"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Peptide Fragments"}, {"RegistryNumber": "0", "NameOfSubstance": "Phosphatidylcholines"}, {"RegistryNumber": "0", "NameOfSubstance": "Pulmonary Surfactant-Associated Protein A"}, {"RegistryNumber": "0", "NameOfSubstance": "SFTPA1 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "SFTPA2 protein, human"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "CHO Cells"}, {"QualifierName": [], "DescriptorName": "Cricetinae"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug effects"], "DescriptorName": "Oxidation-Reduction"}, {"QualifierName": ["toxicity"], "DescriptorName": "Ozone"}, {"QualifierName": ["chemistry", "genetics", "metabolism", "physiology"], "DescriptorName": "Peptide Fragments"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Phosphatidylcholines"}, {"QualifierName": ["cytology", "metabolism"], "DescriptorName": "Pulmonary Alveoli"}, {"QualifierName": ["analogs & derivatives", "chemistry", "genetics", "metabolism", "physiology"], "DescriptorName": "Pulmonary Surfactant-Associated Protein A"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}, {"QualifierName": [], "DescriptorName": "Sequence Analysis, Protein"}, {"QualifierName": [], "DescriptorName": "Sequence Homology, Amino Acid"}, {"QualifierName": [], "DescriptorName": "Transfection"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2004", "Month": "4", "Day": "7", "Hour": "5", "Minute": "0"}, {"Year": "2004", "Month": "8", "Day": "7", "Hour": "5", "Minute": "0"}, {"Year": "2004", "Month": "4", "Day": "7", "Hour": "5", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["15065867", "10.1021/bi036023i"]}}], "PubmedBookArticle": []}